| Chair: Prof Richard Sutton, Dr Robert Sheldon | London, UK, Calgary, CA | |||
|---|---|---|---|---|
| 08:30 | Syncope 101: what they do and don't teach you about assessment | Prof Carlos Morillo | Calgary, CA | |
| 08:50 | Syncope 102: managing a chronic problem not taught in medical school | Dr Melanie Dani | London, UK | |
| 09:10 | PoTS: is tachycardia just the tip of an iceberg? | Prof David Benditt | Minneapolis, US | |
| 09:30 | Grappling with PoTS symptoms and their management | Dr Lesley Kavi | Warwickshire, UK | |
| 09:50 | Final discussion | |||
| 10:00 | Close |
| Chair: Mr James Elliott | London, UK | |||
|---|---|---|---|---|
| Panel | Dr Honey Thomas, Mrs Karen Potts | Ashington, UK, Middlesbrough, UK | ||
| 10:00 | Close |
Arrhythmia Alliance and European Heart Rhythm Association Symposia - Secondary, Provokable, Transient Cause Atrial Fibrillation - Networking Area 1 - 08:30 - 10:00 | Chair: | ||||
|---|---|---|---|---|
| 08:30 | Cardiac and non-cardiac surgery | |||
| 08:50 | Acute myocardial infarction | Prof Sana Al-Khatib | Raleigh, US | |
| 09:10 | Toxicity – endogenous/medical therapy/recreational drugs | |||
| 09:30 | Autonomic events | Prof Carlos Morillo | Calgary, CA | |
| 09:50 | Final discussion | |||
| 10:00 | Close |
| Chair: Dr Angela Griffiths, Dr Angela Hall | Oxford, UK, St Helier, JE | |||
|---|---|---|---|---|
| 08:30 | Arrhythmic presentation in the cardiac sarcoidosis population | Miss Hannah de la Salle | London, UK | |
| 08:45 | Medication challenges in heart failure related AF | Dr James Gamble | Oxford, UK | |
| 09:00 | What do AF patients need from arrhythmia nurses? | Mrs Carolyn Campbell-Cole | London, UK | |
| 09:15 | What patients notice that clinicians don’t – and why it matters | |||
| 09:30 | Secondary prevention AF clinic | |||
| 09:45 | Challenges and experiences of setting up a new arrhythmia service | Ms Wendy Wardle | Carlisle, UK | |
| 10:00 | Close |
| Chair: Dr Rainer Fortner | Merthyr Tydfil, UK | |||
|---|---|---|---|---|
| 08:30 | Physiology of the cardiac conduction system | |||
| 08:50 | Embryology of the cardiac conduction system and neural input to the heart and conduction system | |||
| 09:10 | Anatomy of the left and right atria and conduction system for electrophysiologists | |||
| 09:30 | Anatomy of the right and left ventricle and conduction system for electrophysiologists | |||
| 09:50 | Questions | |||
| 10:00 | Close |
| Further details coming soon |
Arrhythmia Alliance and World Society of Arrhythmias Symposia - What Is New in Afib - Hall 11a - 10:45 - 12:15 | Chair: Prof Thomas Deering | Atlanta, US | |||
|---|---|---|---|---|
| LAAO: to do, or not to do, that is the question: whether 'tis nobler to proceed or refrain | ||||
| 10:45 | Debate: most at-risk patients should undergo LAAO. PRO | |||
| 10:55 | Debate: most at-risk patients should be treated with an OAC. CON | |||
| 11:05 | Rebuttal | |||
| 11:15 | Q&A/moderated discussion | |||
| Chair: | ||||
| Antiarrhythmic drugs for 1st line AF rhythm control: preference or poison? | ||||
| 11:30 | Debate: most patients < 65 with minimal co-morbidities should undergo AF ablation as the 1st rhythm control approach. PRO | Prof Carlos Morillo | Calgary, CA | |
| 11:40 | Debate: most patients < 65 with minimal co-morbidities should receive an antiarrhythmic drug as the 1st rhythm control approach. CON | |||
| 11:50 | Rebuttal | |||
| 12:00 | Q&A/moderated discussion | |||
| 12:15 | Close |
| Chair: Prof David Benditt, Prof Richard Sutton | Minneapolis, US, London, UK | |||
|---|---|---|---|---|
| 10:45 | The STARS syncope survey of NHS trusts in England and Scotland | Mr Nigel Breakwell | London, UK | |
| 11:05 | What does the STARS survey reveal and what is being done? | Miss Cristiana Monteiro | London, UK | |
| 11:25 | Syncope recurrence: is it common and how to manage it? | |||
| 11:45 | The ASPIRED trial results: immediate 14-day ambulatory ECG vs standard monitoring in acute unexplained syncope | Prof Matt Reed | Edinburgh, UK | |
| 12:05 | Final discussion | |||
| 12:15 | Close |
| Chair: Dr Milena Leo, Dr Senthil Kirubakaran | Portsmouth, UK, Portsmouth, UK | |||
|---|---|---|---|---|
| 10:45 | Pulsed field ablation for AF: are we entering the post-thermal era? | Dr Richard Balasubramaniam | Bournemouth, UK | |
| 11:05 | Anticoagulation after AF ablation: can we safely stop? | |||
| 11:25 | Future VT ablation: better energy (PFA)? | Dr John Silberbauer | Brighton, UK | |
| 11:45 | Future VT ablation: better mapping (functional)? | Prof Tarv Dhanjal | Coventry, UK | |
| 12:05 | Final discussion | |||
| 12:15 | Close |
| Chair: Dr Shouvik Haldar | London, UK | |||
|---|---|---|---|---|
| 10:45 | Concomitant LAAO and AF ablation – who is it right for? | |||
| 11:00 | Guideline directed AF management – STEERing in the right direction | Prof Dipak Kotecha | Birmingham, UK | |
| 11:15 | Upstream and post ablation therapy for AF in 2026 | Dr Manish Kalla | Birmingham, UK | |
| 11:30 | Heart failure and AF – who should we offer AF ablation? | |||
| 11:45 | Challenges in AF ablation in ACHD patients | |||
| 12:00 | What does meaningful PPI actually look like? | |||
| 12:15 | Close |
| Chair: Dr Anjum Gandhi, Prof Artur Fedorowski | Birmingham, UK, Solna, SE | |||
|---|---|---|---|---|
| 10:45 | Debate: PoTS it exists in childhood – Diagnostic tools and criteria: Protagonist | Dr Helen Eftekhari | Coventry, UK | |
| 11:05 | Debate: PoTS does not exist in childhood – Antagonist | |||
| 11:25 | Inappropriate sinus tachycardia in childhood: What is it? | Dr Michael Harris | Birmingham, UK | |
| 11:45 | Breath holding spells in childhood: Is it a neurological or cardiac problem? | Prof Cem Karadeniz | Izmir, TR | |
| 12:05 | Questions | |||
| 12:15 | Close |
| Chair: Dr Angela Griffiths, Dr Angela Hall | Oxford, UK, St Helier, JE | |||
|---|---|---|---|---|
| Further details coming soon |
| Chair: Dr John Silberbauer, Dr Richard Balasubramaniam | Brighton, UK, Bournemouth, UK | |||
|---|---|---|---|---|
| 13:30 | PFA workflows with sedation vs GA | |||
| 13:40 | Is there a role for the LAAO in current practice and what is the evidence? | Dr Mauro Lencioni | Birmingham, UK | |
| 13:50 | Can anticoagulation be stopped after AF ablation – who, when, how long? | |||
| 14:00 | First-time persistent AF where the LA is big but normal voltage – what should we do? | Dr Antonio Frontera | Milan, IT | |
| 14:10 | AI in AF ablation – is it ready to be the workhorse of PsAF ablation? | Prof Fu Siong Ng | London, UK | |
| 14:20 | Focal PF with established catheters or is the larger footprint better? | |||
| 14:30 | Designing trials and digital tools that patients will actually engage with | |||
| 14:40 | Final discussion | |||
| 15:00 | Close |
| Chair: Dr Lara Mitchell, Dr Russell Hewett | Glasgow, UK, Glasgow, UK | |||
|---|---|---|---|---|
| 13:30 | Overview of syncope the Glasgow way | Dr Lara Mitchell | Glasgow, UK | |
| Cases with discussion | ||||
| 13:40 | What a cardiologist adds | |||
| 14:00 | What a neurologist adds | Dr Russell Hewett | Glasgow, UK | |
| 14:20 | What a geriatrician adds | Dr Lara Mitchell | Glasgow, UK | |
| 14:40 | How we all work together | Dr Lara Mitchell, Dr Russell Hewett | Glasgow, UK, Glasgow, UK | |
| 14:45 | Advocacy in action: scaling patient voice from clinic to policy | |||
| 15:00 | Close |
| Chair: Prof Aldo Rinaldi | London, UK | |||
|---|---|---|---|---|
| 13:30 | Lead management strategies 2026: top 10 take-home messages | Dr Daniel Keene | London, UK | |
| 14:00 | EHRA CSP 2025 consensus statement: top 10 take-home messages | |||
| 14:30 | NICE leadless guidelines: what does it mean in 2026 – is it fit for purpose or too restrictive? | Dr David Sharman | Northampton, UK | |
| 15:00 | Close |
| Further details coming soon |
| Chair: Prof Orhan Uzun | Cardiff, UK | |||
|---|---|---|---|---|
| 13:30 | Fascicular VT: What a paediatrician should know? | Dr Vinay Bhole | Birmingham, UK | |
| 13:50 | Non-sustained VT on Holter: Should we be worried and how to monitor and investigate? | Dr William Regan | London, UK | |
| 14:10 | RVOT VT: How benign is it? | |||
| 14:30 | PVCs in children: How and when to investigate, and how to manage? | Dr Michael Bowes | Liverpool, UK | |
| 14:50 | Questions | |||
| 15:00 | Close |
| Further details coming soon |
Arrhythmia Alliance and Heart Rhythm Society Symposia - Cutting-Edge Practice in Managing Patients with Ventricular Arrhythmias - Hall 11a - 15:45 - 17:15 | Chair: Prof Sana Al-Khatib | Raleigh, US | |||
|---|---|---|---|---|
| 15:45 | The latest advances in ICD therapy for patients with ventricular arrhythmias | Prof Sana Al-Khatib | Raleigh, US | |
| 16:05 | Catheter ablation as first-line therapy for ventricular tachycardia | Prof G. Andre Ng | Leicester, UK | |
| 16:25 | Pulsed field ablation for ventricular arrhythmias | |||
| 16:45 | AI and ablation of ventricular arrhythmias | |||
| 17:05 | Final discussion | |||
| 17:15 | Close |
| Chair: Prof Carlos Morillo, Prof Richard Sutton | Calgary, CA, London, UK | |||
|---|---|---|---|---|
| 15:45 | Debate: the world needs thousands of syncope specialists | |||
| 15:55 | Debate: the world does not need thousands of syncope specialists | Dr Robert Sheldon | Calgary, CA | |
| 16:05 | Rebuttal | |||
| 16:15 | Q&A/moderated discussion | |||
| 16:30 | Debate: syncope clinics are better than syncope pathways | |||
| 16:40 | Debate: syncope clinics are not better than syncope pathways | Dr Melanie Dani | London, UK | |
| 16:50 | Rebuttal | |||
| 17:00 | Q&A/moderated discussion | |||
| 17:15 | Close |
| Chair: Dr Gamith Adasuriya, Dr Rebecca Griffiths | London, UK, London, UK | |||
|---|---|---|---|---|
| 15:45 | Novel strategies to guide ablation in EP using cardiac digital twins – ventricular arrhythmias | Dr Michael Waight | London, UK | |
| 16:00 | Novel strategies to guide ablation in EP using cardiac digital twins – atrial arrhythmias | |||
| 16:15 | AF ablation – tips and tricks from an electrophysiologist | |||
| 16:30 | AF ablation – tips and tricks from an EP fellow | |||
| 16:45 | Approach to sudden cardiac death in inherited arrhythmia syndromes | Dr Mihnea Casian | London, UK | |
| 17:00 | Risk stratification in inherited arrhythmia syndromes and emerging role of AI | |||
| 17:15 | Close |
| Chair: Dr Angela Griffiths, Dr Angela Hall | Oxford, UK, St Helier, JE | |||
|---|---|---|---|---|
| 15:45 | Island to island arrhythmia care | Dr Angela Griffiths, Dr Angela Hall | Oxford, UK, St Helier, JE | |
| 16:00 | Challenges of managing complex arrhythmia presentations within a DGH | Mrs Kayleigh Mandley | Peterborough, UK | |
| 16:15 | What would you do? Case scenario (AF and HF) | Mr Grant Gillett | Liverpool, UK | |
| 16:30 | Sustainability in CRM | |||
| 16:45 | Rhythm, risks and reinvention: evolving clinical skills from arrhythmia to ICC care | |||
| 17:00 | Final discussion | |||
| 17:15 | Close |
| Chair: Dr Vinay Bhole , Dr William Regan | Birmingham, UK, London, UK | |||
|---|---|---|---|---|
| 15:45 | WPW syndrome: How to investigate, treat, and manage in infants and when is the best time for ablation in resistant cases | |||
| 16:05 | Familial WPW syndromes and their management outcomes | Dr Charalampos Kotidis | Leicester, UK | |
| 16:25 | WPW syndrome: Principles of EP study – tips and tricks | |||
| Chair: Dr Max Nathan | UK | |||
| 16:45 | Oral Presentations - further details coming soon | |||
| 17:15 | Questions | |||
| 17:30 | Close |